Esmultivita Injection

Adult administration

For children over 11 years and adults, shake 5 mL of sterile water for injection gently to dissolve, then mix with 500–1,000 mL of intravenous glucose injection, normal saline, or similar infusion solutions and administer via intravenous drip once a day.

Child administration

For children over 11 years and adults, shake 5 mL of sterile water for injection gently to dissolve, then mix with 500–1,000 mL of intravenous glucose injection, normal saline, or similar infusion solutions and administer via intravenous drip within 5 minutes.

This drug should not be administered more than 5,000 IU of vitamin A daily in women within the first 3 months of pregnancy or those who may become pregnant, as vitamin A may pose a risk of congenital malformations. Patients allergic to any components contained in this drug or patients with hemophilia should not use this medication, as there may be prolonged bleeding in hemophilia patients. Patients with hypercalcemia may experience elevated calcium levels due to the vitamin D contained in this drug, and their conditions should be monitored through blood and urine tests; if any abnormalities are found, administration should be discontinued. Patients with impaired kidney function should use this drug with caution as vitamin D can elevate blood calcium levels and worsen kidney function. This drug is not recommended for use in children under 11 years of age, as its safety and efficacy have not been established. Patients with allergic predisposition such as bronchial asthma, rash, urticaria, or a history of drug hypersensitivity should be administered this medication with caution. Overdosage may lead to allergic reactions or severe shock symptoms related to vitamins A and D; if such symptoms occur, medication should be stopped immediately and appropriate treatment should be administered. Long-term use may lead to accumulation of vitamins A and D in the body, so regular check-ups are necessary. This medication may interact with certain drugs, so it should not be used with acetazolamide, chlorothiazide sodium, tetracycline hydrochloride, etc. Additionally, it may react with vitamin K and reduce the effectiveness of levodopa medications. Pregnant or breastfeeding women should take care not to overdose on vitamins, especially during the early stages of pregnancy, where limits on dosage should be carefully observed. Elderly patients should have their dosages adjusted due to possible decline in bodily functions. This medication may affect the results of some clinical tests, such as urine sugar tests or stool occult blood tests, so it's important to consider this during testing. When using as an injection, it should be used immediately after opening, and any remaining should be discarded. As it contains ingredients sensitive to light, care should be taken in storage. Store in a place out of reach of children, keep refrigerated, and avoid freezing. It is safest to store in its original container.

Serious side effects

• Shock
• anaphylactic symptoms
• respiratory distress

Mild side effects

• Itching
• sweating
• hypotension
• consciousness disturbance
• cyanosis
• nausea
• chest discomfort
• facial flushing
• dizziness
• fainting

This medication should be stored in a sealed container to prevent air or moisture from entering and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and safety.

Appearance

A freeze-dried injection in a brown vial containing a yellow lump.

Package unit

10 vials